Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Criteo (CRTO) Cash & Equivalents (2016 - 2026)

Criteo has reported Cash & Equivalents over the past 15 years, most recently at $320.0 million for Q1 2026.

  • Quarterly results put Cash & Equivalents at $320.0 million for Q1 2026, up 11.94% from a year ago — trailing twelve months through Mar 2026 was $320.0 million (up 11.94% YoY), and the annual figure for FY2025 was $342.0 million, up 17.66%.
  • Cash & Equivalents reached $320.0 million in Q1 2026 per CRTO's latest filing, down from $342.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $589.3 million in Q1 2022 and bottomed at $48.3 million in Q2 2022.
  • Median Cash & Equivalents over the past 5 years was $276.4 million (2024), compared with a mean of $266.4 million.
  • The largest annual shift saw Cash & Equivalents tumbled 90.13% in 2022 before it soared 361.96% in 2023.
  • Over 5 years, Cash & Equivalents stood at $348.2 million in 2022, then decreased by 3.41% to $336.3 million in 2023, then decreased by 13.57% to $290.7 million in 2024, then rose by 17.66% to $342.0 million in 2025, then dropped by 6.45% to $320.0 million in 2026.
  • Business Quant data shows Cash & Equivalents for CRTO at $320.0 million in Q1 2026, $342.0 million in Q4 2025, and $205.7 million in Q2 2025.